May 7
Current report
8-K
Events of May 5
Entered into a material agreement
PASG · Passage BIO, Inc. · Documents
$4.01
+0.01 (+0.25%)
At close · Nov 12
Return incl. dividend (before tax)
Q4 2022 earnings call transcript
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, there is substantial doubt about the Company's ability to continue as a going concern within one year after the date that these consolidated financial statements are issued.”View the 10-Q filed Aug 10, 2026
Market Cap
$12.90M
Shares
3.22M
Volume · Nov 12
12.63K
Avg daily vol (3M)
20.62K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2020
Apr 14
Current report
8-K
Events of Apr 10
Entered into a material agreement
Apr 3
Current report
8-K
Regulation FD disclosure, Other events
Mar 27
Current report
8-K
Events of Mar 26
Charter or bylaw amendment, or fiscal year change
Feb 27
Registration statement
S-1/A
Registration statement
Feb 18
Registration statement
S-1/A
Registration statement
Feb 3
Registration statement
S-1
Registration statement
Showing 151–157 of 157 documents
Key facts
CIK
1787297
CUSIP
702712209
13F (30d)
25 filings
14 filers
Visit website
Investor relations